A case series which is the result of an international collaboration across 16 countries is published today (21 July 2022) in The New England Journal of Medicine (NEJM). The study, led by researchers at Queen Mary University of London, identifies new clinical symptoms of monkeypox infection, which will aid futureContinuar Leyendo
Mycobacterium tuberculosis, the causative agent of tuberculosis, remains the leading cause of infectious disease worldwide, affecting approximately a quarter of the globe’s population. Treatment of infections is problematic due to the emergence of drug-resistant strains; however, University of Oklahoma professor Helen Zgurskaya, an expert in antibiotic resistance, is leading researchContinuar Leyendo
Colorectal tumors are swarming with white blood cells, but whether these cells help or hinder the cancer is hotly debated. While some studies have shown that white blood cells heroically restrict tumor growth and combat colorectal cancer, equally compelling evidence casts the white blood cells as malignant co-conspirators — bolsteringContinuar Leyendo
Cancer cells produce small amounts of their own form of collagen, creating a unique extracellular matrix that affects the tumor microbiome and protects against immune responses, according to a new study by researchers at The University of Texas MD Anderson Cancer Center. This abnormal collagen structure is fundamentally different fromContinuar Leyendo
A team of Florida State University College of Medicine researchers has found a link between a specific protein in the brain and increased vulnerability to neurodegeneration for individuals with temporal lobe epilepsy (TLE). Tallahassee, FL, July 20, 2022.- Their findings are published in the Journal of Neurophysiology. TLE is theContinuar Leyendo
Yale scientists have developed a novel Omicron-specific mRNA vaccine that offers superior immune protection against two viral subvariants than standard mRNA vaccines. New Haven, CT, July 20, 2022.- The new vaccine, called Omnivax, increased neutralizing antibody response against the BA.1 and BA.2.12.1 Omicron subvariants in pre-immunized mice 19-fold and eight-fold,Continuar Leyendo
Although antiretroviral therapy has markedly improved survival in people with AIDS-associated Kaposi sarcoma (a type of cancer caused by a virus), the condition is still a life-threatening problem in low- and middle-income countries. Boston, July 17, 2022.- New research led by researchers at Massachusetts General Hospital (MGH) with Ugandan andContinuar Leyendo
Brain metastasis is one of the most common causes of cancer-related deaths and occurs very frequently in patients with advanced melanoma. Although new immunotherapies are effective in some patients with melanoma brain metastases, little is known about the reasons for melanoma’s spread to the brain and the lower response ratesContinuar Leyendo
In a new proof-of-concept study led by Dr. Mark Walker at the University of Ottawa’s Faculty of Medicine, researchers are pioneering the use of a unique Artificial Intelligence-based deep learning model as an assistive tool for the rapid and accurate reading of ultrasound images. Ottawa, July 15, 2022.- The goalContinuar Leyendo
It takes a lot of time — and money — to diagnose Alzheimer’s disease. After running lengthy in-person neuropsychological exams, clinicians have to transcribe, review, and analyze every response in detail. But researchers at Boston University have developed a new tool that could automate the process and eventually allow itContinuar Leyendo
